Method For The Diagnosis Of Neuromyelitis Optica
|Document №||Publication date||Filed Date||Application №|
|20160054318||February 25, 2016||March 28, 2014||14/780617|
The present invention relates to a method for the diagnosis and/or risk stratification of neuromyelitis optica (abbreviated NMO), wherein a determination from a body sample of a patient/test subject is performed by means of artificial aquaporin-4 peptides. The invention further relates to a kit and to new artificial aquaporin-4 peptides as such.